help button home button The Oncologist http://theoncologist.alphamedpress.org/misc/eLetters.shtml
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
The Oncologist, Vol. 11, No. 9, 1034-1044, October 2006; doi:10.1634/theoncologist.11-9-1034
© 2006 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
 Photodynamic Therapy in Oncology
Right arrow eLetters: Submit a response to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Triesscheijn, M.
Right arrow Articles by Stewart, F. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Triesscheijn, M.
Right arrow Articles by Stewart, F. A.

Radiation Oncology

Photodynamic Therapy in Oncology

Martijn Triesscheijna, Paul Baasa,b, Jan H. M. Schellensa,b,c, Fiona A. Stewarta

a Division of Experimental Therapy (H6) and b Department of Medical Oncology, The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; c Faculty of Pharmaceutical Sciences, Division of Drug Toxicology, Utrecht University, Utrecht, The Netherlands

Key Words. Photodynamic therapy • Photofrin • Aminolevulinic acid • mTHPC

Correspondence: Fiona A. Stewart, Ph.D., Division of Experimental Therapy (H6), The Netherlands Cancer Institute/Antoni van Leeu-wenhoek Hospital, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. Telephone: 31-20-512-2036; Fax: 31-20-512-2050; e-mail: f.stewart{at}nki.nl

Photodynamic therapy (PDT) is increasingly being recognized as an attractive, alternative treatment modality for superficial cancer. Treatment consists of two relatively simple procedures: the administration of a photosensitive drug and illumination of the tumor to activate the drug. Efficacy is high for small superficial tumors and, except for temporary skin photosensitization, there are no long-term side effects if appropriate protocols are followed. Healing occurs with little or no scarring and the procedure can be repeated without cumulative toxicity. Considering the efficacy and lack of long-term toxicity of PDT, and the fact that the first treatment of cancer with PDT was done more than 100 years ago, one might expect that this treatment had already become an established therapy. However, PDT is currently offered in only a few selected centers, although it is slowly gaining acceptance as an alternative to conventional cancer therapies. Here, we show the developmental steps PDT underwent and summarize the current clinical applications. The data show that, when properly used, PDT is an effective alternative treatment option in oncology.




This article has been cited by other articles:


Home page
 J Ultrasound MedHome page
W. Tang, Q. Liu, X. Wang, P. Wang, B. Cao, N. Mi, and J. Zhang
Involvement of Caspase 8 in Apoptosis Induced by Ultrasound-Activated Hematoporphyrin in Sarcoma 180 Cells In Vitro
J. Ultrasound Med., April 1, 2008; 27(4): 645 - 656.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Ferrario, N. Rucker, S. Wong, M. Luna, and C. J. Gomer
Survivin, a Member of the Inhibitor of Apoptosis Family, Is Induced by Photodynamic Therapy and Is a Target for Improving Treatment Response
Cancer Res., May 15, 2007; 67(10): 4989 - 4995.
[Abstract] [Full Text] [PDF]


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS
http://theoncologist.alphamedpress.org/subscriptions/etoc.dtl

Copyright © 2006 by AlphaMed Press.